Doctors order ‘absolute rest’ for Pope Francis while he’s being treated for a respiratory infection
The Vatican says Pope Francis slept well during a quiet first night in the hospital after being admitted with a respiratory ...
Pope Francis 'responding to therapy' for double pneumonia but still 'not out of danger'
Pope Francis is "responding to therapy" for double pneumonia at a hospital in Rome but it not "not out of danger," the ...
Seattle Weekly2d
Breathe Respiratory Blend Drops Helped Me Breathe Easier—Here’s My Experience
In today’s fast-paced world, respiratory health has become a significant concern for many individuals. Conditions such as ...
WDRB9d
Bellarmine University updates respiratory therapy program to offer quicker path to careers
Bellarmine University updated its graduate respiratory therapy program to be the fastest entry-to-practice practice in the ...
Pope will remain hospitalized as doctors treat a complex respiratory tract infection, Vatican says
The Vatican says Pope Francis’ respiratory tract infection is presenting a “complex clinical picture” that will require ...
The Christian Post on MSN5d
Pope Francis hospitalized, battling ‘complex’ respiratory illness
Pope Francis remains in good spirits as he battles a respiratory infection that required the 88-year-old head of the Roman ...
Pope Francis to remain hospitalized for respiratory tract infection
Pope Francis has been in the hospital since Friday with a respiratory tract infection. Officials with the Vatican said Monday ...
News Medical on MSN21h
Targeted mRNA therapy shows promise for healing damaged lungs
A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...
Pope Francis stable as he remains hospitalized for 'complex' respiratory infection
The pope, 88, was diagnosed with a polymicrobial infection after he was hospitalized in Rome on Friday for bronchitis.
EurekAlert!2d
Novel inhalable gene therapy trialled for people with cystic fibrosis
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.